Bupivacaine Injections Into Uterosacral Ligaments During Robotic Assisted Total Hysterectomies

Withdrawn before enrolling · Not applicable · Has a placebo group

Conditions studied: Pain

In brief

Will patients that receive injections of Marcaine into the uterine nerve via the uterosacral ligaments experience less pain postoperatively, need less narcotic pain medication and return to activities of daily living sooner.

Key facts

Study ID

NCT02230735

Run by

Souza, Amanda, M.D.

People needed

0

Starts

2014-08-01

Expected to finish

2014-08-01

Last updated by the study team

2016-05-05

Who can join

Age: 21 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing robotically assisted total hysterectomies with cystoscopy and with or without procedures involving the adnexa (salpingectomies and salpingo-oophorectomies)

You may not qualify if…

• Patients undergoing single incision procedures, those having supracervical hysterectomies and additional procedures involving their pelvic floor (including bladder neck suspension, anterior colophorraphy, posterior colophorraphy, perinealplasty) and sacracolpopexy
• Patients with allergies to bupivacaine and its derivatives
• Patients taking monoamine oxidase inhibitors or tricyclic antidepressants
• Patients with known clinically significant hepatic, gastrointestinal, renal, haematological, urologic, neurological, respiratory, endocrine or cardiovascular system abnormalities
• Patients with abnormal ECG's and prolonged QT syndrome
• Patients who are currently requiring narcotic pain medication or use narcotic pain medications regularly (more than twice weekly)

Where it is running

• Botsford General Hospital — Farmington Hills, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.